Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Alder BioPharmaceuticals Inc. ALDR

Healthcare Biotechnology
Alder BioPharmaceuticals Inc is a biotechnology company that seeks to discover, develop, and commercialize therapeutic antibodies. The company's antibody platform seeks to maximize efficacy, as well as the speed of onset and durability of therapeutic response. Alder's product pipeline addresses diseases where patients have limited medical options or where current medical options may not meet... see more

Recent & Breaking News (NDAQ:ALDR)

Lundbeck and Alder BioPharmaceuticals announce updated information in the tender offer materials filed with SEC

GlobeNewswire October 11, 2019

Alder BioPharmaceuticals® Announces First-in-Human Dosing in Phase 1 ALD1910 Study for Preventive Treatment of Migraine

GlobeNewswire October 10, 2019

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Alder BioPharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Business Wire October 1, 2019

MERGER ALERT -SEMG, ALDR, and HLND: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies

GlobeNewswire September 27, 2019

MERGER ALERT - UCFC and ALDR: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies

GlobeNewswire September 23, 2019

Shareholder Investigation Alert: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies is Fair to Shareholders - UCFC, SEMG, ALDR, FCSC

GlobeNewswire September 23, 2019

CBM, SEMG, ALDR: Monteverde & Associates PC Reminds Investors of an Ongoing Inquiry Regarding the Acquisition

ACCESSWIRE IA September 20, 2019

ALDR, MAMS, BKJ, and SRCI SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts

GlobeNewswire September 19, 2019

SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Alder BioPharmaceuticals, Inc. - ALDR

ACCESSWIRE IA September 17, 2019

SHAREHOLDER ALERT: WeissLaw LLP Investigates Alder Biopharmaceuticals, Inc.

PR Newswire September 17, 2019

Shareholder Investigation Alert: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies is Fair to Shareholders - PVTL, UCFC, SEMG, ALDR

GlobeNewswire September 17, 2019

Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR) on Behalf of Alder Shareholders and Encourages Alder Investors to Contact the Firm

PR Newswire September 16, 2019

ALDER BIOPHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout

ACCESSWIRE IA September 16, 2019

Alder Merger Investigation: Halper Sadeh LLP Announces Investigation into Whether the Sale of Alder Biopharmaceuticals, Inc. is Fair to Shareholders; Investors Are Encouraged to Contact The Firm - ALDR

GlobeNewswire September 16, 2019

Shareholder Alert: Ademi & O'Reilly, LLP Investigates whether Alder BioPharmaceuticals has obtained a Fair Price in its sale to H. Lundbeck A/S

PR Newswire September 16, 2019

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Alder BioPharmaceuticals, Inc. to H. Lundbeck A/S is Fair to Shareholders

GlobeNewswire September 16, 2019

Alder (ALDR) Alert: Johnson Fistel Investigates Proposed Sale of Alder BioPharmaceuticals, Inc.; Are Shareholders Getting a Fair Deal?

PR Newswire September 16, 2019

Lundbeck to acquire Alder BioPharmaceuticals - a company committed to transforming migraine treatment and prevention - in a transaction valued at up to USD 1.95 billion net of cash

GlobeNewswire September 16, 2019

Alder BioPharmaceuticals® to Showcase Data from Migraine Prevention Portfolio at 19th Congress of the International Headache Society

GlobeNewswire September 5, 2019

Bolt Biotherapeutics Appoints Veteran Executive Randall Schatzman as CEO to Lead the Next Phase of Growth

PR Newswire September 4, 2019